 Vikhyat Bebarta
Concepts (612)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antidotes | 35 | 2024 | 136 | 12.140 |
Why?
| | Military Personnel | 51 | 2024 | 515 | 10.170 |
Why?
| | Cyanides | 27 | 2024 | 51 | 7.810 |
Why?
| | Wounds and Injuries | 36 | 2025 | 711 | 7.430 |
Why?
| | Hydroxocobalamin | 17 | 2020 | 26 | 6.940 |
Why?
| | Emergency Medical Services | 32 | 2024 | 522 | 6.690 |
Why?
| | Air Ambulances | 15 | 2024 | 32 | 4.350 |
Why?
| | Resuscitation | 15 | 2024 | 237 | 4.120 |
Why?
| | Afghan Campaign 2001- | 31 | 2024 | 130 | 3.900 |
Why?
| | Military Medicine | 15 | 2022 | 62 | 3.720 |
Why?
| | Swine | 38 | 2024 | 760 | 3.680 |
Why?
| | Cobamides | 8 | 2022 | 20 | 3.600 |
Why?
| | Thiosulfates | 8 | 2021 | 19 | 3.170 |
Why?
| | Hydrogen Sulfide | 7 | 2022 | 42 | 2.950 |
Why?
| | Potassium Cyanide | 8 | 2021 | 18 | 2.830 |
Why?
| | Infusions, Intraosseous | 10 | 2024 | 17 | 2.710 |
Why?
| | Poisoning | 9 | 2023 | 111 | 2.570 |
Why?
| | Hypotension | 11 | 2021 | 116 | 2.460 |
Why?
| | Warfare | 13 | 2023 | 63 | 2.420 |
Why?
| | Critical Care | 12 | 2024 | 553 | 2.380 |
Why?
| | Apnea | 5 | 2020 | 20 | 2.290 |
Why?
| | Hospitals, Military | 9 | 2018 | 25 | 2.260 |
Why?
| | Emergency Medicine | 10 | 2018 | 215 | 2.210 |
Why?
| | Intubation, Intratracheal | 10 | 2024 | 239 | 2.080 |
Why?
| | Airway Management | 5 | 2019 | 44 | 2.080 |
Why?
| | Heart Arrest | 8 | 2024 | 321 | 2.030 |
Why?
| | Emergency Service, Hospital | 17 | 2024 | 1902 | 2.010 |
Why?
| | Hydrocodone | 5 | 2019 | 16 | 1.990 |
Why?
| | Analgesics, Opioid | 15 | 2020 | 913 | 1.970 |
Why?
| | Iraq War, 2003-2011 | 19 | 2024 | 125 | 1.930 |
Why?
| | Disease Models, Animal | 28 | 2023 | 4063 | 1.830 |
Why?
| | Hemorrhage | 10 | 2024 | 678 | 1.700 |
Why?
| | Sulfides | 7 | 2022 | 94 | 1.690 |
Why?
| | Analgesics | 5 | 2024 | 189 | 1.680 |
Why?
| | Afghanistan | 16 | 2024 | 70 | 1.650 |
Why?
| | Laryngoscopes | 4 | 2024 | 34 | 1.590 |
Why?
| | Antidepressive Agents, Tricyclic | 6 | 2014 | 30 | 1.580 |
Why?
| | Transportation of Patients | 3 | 2018 | 50 | 1.570 |
Why?
| | Critical Illness | 12 | 2025 | 758 | 1.560 |
Why?
| | Ketamine | 6 | 2024 | 85 | 1.560 |
Why?
| | Mass Casualty Incidents | 7 | 2022 | 36 | 1.520 |
Why?
| | Humans | 168 | 2025 | 129622 | 1.490 |
Why?
| | Shock, Hemorrhagic | 6 | 2024 | 165 | 1.490 |
Why?
| | Brain Injuries, Traumatic | 6 | 2023 | 341 | 1.480 |
Why?
| | Injury Severity Score | 16 | 2024 | 509 | 1.400 |
Why?
| | Cardiopulmonary Resuscitation | 5 | 2020 | 232 | 1.340 |
Why?
| | Male | 98 | 2025 | 63674 | 1.330 |
Why?
| | Female | 94 | 2025 | 68770 | 1.320 |
Why?
| | Sulfhydryl Compounds | 5 | 2022 | 187 | 1.320 |
Why?
| | Airway Obstruction | 3 | 2018 | 152 | 1.310 |
Why?
| | Heart Massage | 3 | 2019 | 7 | 1.270 |
Why?
| | Research | 6 | 2022 | 416 | 1.270 |
Why?
| | Prospective Studies | 30 | 2024 | 7131 | 1.260 |
Why?
| | Retrospective Studies | 43 | 2024 | 14519 | 1.250 |
Why?
| | Toxicology | 4 | 2018 | 41 | 1.230 |
Why?
| | Drug Overdose | 10 | 2016 | 322 | 1.220 |
Why?
| | Animals | 63 | 2024 | 35360 | 1.220 |
Why?
| | Adult | 68 | 2025 | 35572 | 1.210 |
Why?
| | Pressure | 2 | 2020 | 237 | 1.180 |
Why?
| | Registries | 19 | 2024 | 1895 | 1.170 |
Why?
| | Poison Control Centers | 8 | 2017 | 89 | 1.160 |
Why?
| | Patient Transfer | 3 | 2019 | 162 | 1.150 |
Why?
| | Brugada Syndrome | 4 | 2008 | 9 | 1.120 |
Why?
| | Acute Pain | 3 | 2024 | 45 | 1.100 |
Why?
| | Respiration, Artificial | 6 | 2023 | 613 | 1.090 |
Why?
| | Opioid-Related Disorders | 7 | 2019 | 484 | 1.090 |
Why?
| | Amitriptyline | 4 | 2011 | 20 | 1.060 |
Why?
| | Injections, Intramuscular | 8 | 2024 | 116 | 1.030 |
Why?
| | Sodium Nitrite | 4 | 2016 | 39 | 1.020 |
Why?
| | United States | 41 | 2024 | 13900 | 1.000 |
Why?
| | Laryngoscopy | 5 | 2024 | 97 | 1.000 |
Why?
| | Sodium Bicarbonate | 6 | 2016 | 37 | 1.000 |
Why?
| | Random Allocation | 7 | 2020 | 346 | 1.000 |
Why?
| | Pain Measurement | 3 | 2018 | 506 | 0.990 |
Why?
| | Hydrogen Cyanide | 3 | 2022 | 5 | 0.980 |
Why?
| | Pain Management | 5 | 2024 | 327 | 0.970 |
Why?
| | Craniocerebral Trauma | 2 | 2020 | 152 | 0.960 |
Why?
| | War-Related Injuries | 3 | 2021 | 7 | 0.960 |
Why?
| | Wounds, Penetrating | 3 | 2023 | 63 | 0.950 |
Why?
| | Hydromorphone | 3 | 2016 | 9 | 0.950 |
Why?
| | Substance Abuse Detection | 4 | 2019 | 79 | 0.940 |
Why?
| | Blood Transfusion | 7 | 2023 | 296 | 0.930 |
Why?
| | Hemodynamics | 11 | 2023 | 1089 | 0.930 |
Why?
| | Heart Ventricles | 3 | 2020 | 781 | 0.900 |
Why?
| | Remote Consultation | 2 | 2015 | 47 | 0.890 |
Why?
| | Sus scrofa | 8 | 2024 | 46 | 0.880 |
Why?
| | Balloon Occlusion | 2 | 2024 | 34 | 0.870 |
Why?
| | Wounds, Gunshot | 3 | 2022 | 213 | 0.870 |
Why?
| | Snake Bites | 5 | 2019 | 28 | 0.870 |
Why?
| | Freeze Drying | 1 | 2024 | 82 | 0.860 |
Why?
| | Blood Pressure | 10 | 2018 | 1735 | 0.850 |
Why?
| | Time Factors | 15 | 2024 | 6556 | 0.830 |
Why?
| | Tetrathionic Acid | 2 | 2021 | 4 | 0.830 |
Why?
| | Chromatography, Liquid | 4 | 2022 | 423 | 0.830 |
Why?
| | Plasma | 2 | 2024 | 206 | 0.820 |
Why?
| | Environmental Exposure | 4 | 2019 | 463 | 0.820 |
Why?
| | Internship and Residency | 4 | 2016 | 1052 | 0.800 |
Why?
| | Tandem Mass Spectrometry | 5 | 2022 | 524 | 0.790 |
Why?
| | Compartment Syndromes | 1 | 2022 | 22 | 0.760 |
Why?
| | Aorta | 2 | 2024 | 411 | 0.740 |
Why?
| | Acetylcysteine | 2 | 2014 | 146 | 0.740 |
Why?
| | Saline Solution, Hypertonic | 2 | 2014 | 40 | 0.730 |
Why?
| | Young Adult | 28 | 2021 | 12426 | 0.730 |
Why?
| | Iraq | 9 | 2023 | 52 | 0.730 |
Why?
| | Administration, Intravenous | 5 | 2019 | 141 | 0.720 |
Why?
| | Acetaminophen | 3 | 2014 | 246 | 0.710 |
Why?
| | Epinephrine | 5 | 2022 | 141 | 0.700 |
Why?
| | Trauma Centers | 5 | 2025 | 402 | 0.690 |
Why?
| | Pain | 5 | 2018 | 789 | 0.690 |
Why?
| | Blast Injuries | 6 | 2021 | 45 | 0.690 |
Why?
| | Patient Handoff | 1 | 2020 | 31 | 0.680 |
Why?
| | Morphine | 3 | 2017 | 137 | 0.680 |
Why?
| | Thorax | 1 | 2020 | 42 | 0.670 |
Why?
| | Burns | 4 | 2017 | 286 | 0.670 |
Why?
| | Thiadiazoles | 1 | 2020 | 24 | 0.670 |
Why?
| | Cannabinoids | 2 | 2012 | 153 | 0.660 |
Why?
| | Oxygen Inhalation Therapy | 4 | 2025 | 143 | 0.660 |
Why?
| | Administration, Oral | 6 | 2021 | 786 | 0.650 |
Why?
| | Firearms | 3 | 2022 | 359 | 0.650 |
Why?
| | Chemically-Induced Disorders | 1 | 2019 | 2 | 0.640 |
Why?
| | Infusions, Intravenous | 8 | 2020 | 399 | 0.640 |
Why?
| | Antivenins | 4 | 2013 | 35 | 0.640 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2018 | 8 | 0.620 |
Why?
| | Humerus | 3 | 2022 | 41 | 0.600 |
Why?
| | Glycine | 1 | 2019 | 165 | 0.590 |
Why?
| | Amputation, Traumatic | 1 | 2018 | 20 | 0.590 |
Why?
| | Ventricular Fibrillation | 1 | 2018 | 57 | 0.590 |
Why?
| | Nursing Care | 1 | 2018 | 39 | 0.590 |
Why?
| | Cricoid Cartilage | 2 | 2015 | 15 | 0.590 |
Why?
| | Norepinephrine | 1 | 2019 | 210 | 0.580 |
Why?
| | Emergency Treatment | 4 | 2018 | 113 | 0.580 |
Why?
| | Preceptorship | 1 | 2018 | 65 | 0.580 |
Why?
| | Military Facilities | 1 | 2017 | 3 | 0.580 |
Why?
| | Tablets | 1 | 2017 | 36 | 0.570 |
Why?
| | Monitoring, Physiologic | 7 | 2021 | 268 | 0.570 |
Why?
| | Hypocalcemia | 3 | 2023 | 28 | 0.570 |
Why?
| | Fellowships and Scholarships | 3 | 2016 | 273 | 0.570 |
Why?
| | Hyperoxia | 4 | 2023 | 90 | 0.560 |
Why?
| | Chronic Pain | 3 | 2020 | 254 | 0.560 |
Why?
| | Cardiovascular Agents | 1 | 2019 | 156 | 0.550 |
Why?
| | Evidence-Based Emergency Medicine | 2 | 2016 | 3 | 0.550 |
Why?
| | Middle Aged | 32 | 2025 | 31150 | 0.540 |
Why?
| | Treatment Outcome | 16 | 2023 | 10226 | 0.530 |
Why?
| | Oseltamivir | 1 | 2016 | 11 | 0.530 |
Why?
| | Gas Poisoning | 1 | 2016 | 4 | 0.530 |
Why?
| | Tourniquets | 3 | 2021 | 20 | 0.530 |
Why?
| | Emergency Medical Technicians | 1 | 2016 | 38 | 0.520 |
Why?
| | Abdominal Pain | 2 | 2019 | 144 | 0.520 |
Why?
| | Smoke Inhalation Injury | 1 | 2016 | 23 | 0.520 |
Why?
| | Altitude | 1 | 2020 | 461 | 0.510 |
Why?
| | Tranexamic Acid | 3 | 2023 | 37 | 0.500 |
Why?
| | Telemedicine | 2 | 2015 | 788 | 0.500 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2016 | 70 | 0.500 |
Why?
| | Antifibrinolytic Agents | 3 | 2023 | 47 | 0.500 |
Why?
| | Substance-Related Disorders | 4 | 2017 | 1022 | 0.500 |
Why?
| | South Africa | 4 | 2024 | 192 | 0.500 |
Why?
| | Tibia | 2 | 2014 | 170 | 0.490 |
Why?
| | Oxygen | 5 | 2025 | 915 | 0.490 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 875 | 0.480 |
Why?
| | Adolescent | 25 | 2021 | 20391 | 0.480 |
Why?
| | Acidosis, Lactic | 1 | 2015 | 46 | 0.480 |
Why?
| | Hematinics | 1 | 2015 | 19 | 0.470 |
Why?
| | Asphyxia | 1 | 2014 | 20 | 0.470 |
Why?
| | Electrocardiography | 5 | 2012 | 608 | 0.460 |
Why?
| | Diphenhydramine | 2 | 2015 | 31 | 0.460 |
Why?
| | Patient Simulation | 1 | 2014 | 33 | 0.460 |
Why?
| | Efficiency | 1 | 2015 | 91 | 0.450 |
Why?
| | Self Report | 2 | 2017 | 799 | 0.440 |
Why?
| | Awards and Prizes | 1 | 2015 | 63 | 0.440 |
Why?
| | Solvents | 2 | 2004 | 108 | 0.440 |
Why?
| | Tracheotomy | 1 | 2014 | 23 | 0.440 |
Why?
| | Anemia | 1 | 2015 | 160 | 0.440 |
Why?
| | Exsanguination | 1 | 2013 | 19 | 0.440 |
Why?
| | Texas | 5 | 2017 | 228 | 0.420 |
Why?
| | Dietary Supplements | 1 | 2017 | 534 | 0.420 |
Why?
| | Practice Patterns, Physicians' | 3 | 2020 | 1266 | 0.420 |
Why?
| | Tracheostomy | 1 | 2015 | 121 | 0.420 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2013 | 6 | 0.410 |
Why?
| | Incidence | 10 | 2022 | 2644 | 0.410 |
Why?
| | Burns, Chemical | 2 | 2017 | 29 | 0.410 |
Why?
| | Mobile Health Units | 2 | 2012 | 19 | 0.410 |
Why?
| | Glyoxylates | 2 | 2023 | 9 | 0.400 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2014 | 132 | 0.400 |
Why?
| | Forensic Medicine | 1 | 2012 | 18 | 0.400 |
Why?
| | Aerospace Medicine | 3 | 2017 | 23 | 0.400 |
Why?
| | Seizures | 3 | 2013 | 402 | 0.400 |
Why?
| | Methanol | 2 | 2016 | 35 | 0.400 |
Why?
| | Viperidae | 2 | 2011 | 7 | 0.400 |
Why?
| | Chi-Square Distribution | 4 | 2019 | 516 | 0.390 |
Why?
| | Mass Screening | 2 | 2018 | 1149 | 0.380 |
Why?
| | Vitamin B 12 | 1 | 2012 | 122 | 0.370 |
Why?
| | Hyperalgesia | 1 | 2012 | 124 | 0.370 |
Why?
| | Education, Medical | 1 | 2014 | 243 | 0.370 |
Why?
| | Metformin | 1 | 2015 | 315 | 0.370 |
Why?
| | Renal Dialysis | 1 | 2015 | 423 | 0.370 |
Why?
| | Gas Chromatography-Mass Spectrometry | 3 | 2020 | 131 | 0.370 |
Why?
| | Bone and Bones | 1 | 2014 | 299 | 0.360 |
Why?
| | Gait | 1 | 2014 | 280 | 0.360 |
Why?
| | Fires | 1 | 2012 | 88 | 0.360 |
Why?
| | Fluid Therapy | 3 | 2019 | 134 | 0.360 |
Why?
| | Referral and Consultation | 1 | 2016 | 733 | 0.360 |
Why?
| | Injections, Intravenous | 5 | 2018 | 201 | 0.360 |
Why?
| | Extremities | 2 | 2022 | 127 | 0.350 |
Why?
| | Survival Rate | 6 | 2018 | 1877 | 0.350 |
Why?
| | Blood Component Transfusion | 2 | 2024 | 82 | 0.350 |
Why?
| | Waiting Lists | 1 | 2012 | 237 | 0.350 |
Why?
| | Antiviral Agents | 1 | 2016 | 712 | 0.350 |
Why?
| | Lung | 2 | 2020 | 3931 | 0.340 |
Why?
| | Influenza, Human | 1 | 2016 | 601 | 0.340 |
Why?
| | Medical Records | 2 | 2021 | 171 | 0.340 |
Why?
| | Thiocyanates | 5 | 2024 | 31 | 0.330 |
Why?
| | Survival Analysis | 4 | 2021 | 1274 | 0.310 |
Why?
| | Prescription Drug Misuse | 4 | 2020 | 39 | 0.310 |
Why?
| | Guideline Adherence | 4 | 2023 | 526 | 0.310 |
Why?
| | Immunoglobulin Fragments | 1 | 2008 | 11 | 0.310 |
Why?
| | Omeprazole | 1 | 2008 | 6 | 0.300 |
Why?
| | Vascular Resistance | 3 | 2015 | 371 | 0.300 |
Why?
| | Rhabdomyolysis | 1 | 2008 | 22 | 0.290 |
Why?
| | Immunoglobulin Fab Fragments | 2 | 2008 | 59 | 0.290 |
Why?
| | Hyponatremia | 1 | 2008 | 40 | 0.290 |
Why?
| | Hydrothorax | 1 | 2007 | 3 | 0.290 |
Why?
| | Coma | 2 | 2022 | 32 | 0.290 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1279 | 0.290 |
Why?
| | Drug Therapy, Combination | 4 | 2019 | 1040 | 0.280 |
Why?
| | Scalp | 1 | 2007 | 34 | 0.280 |
Why?
| | Physicians | 5 | 2019 | 864 | 0.280 |
Why?
| | Practice Guidelines as Topic | 2 | 2017 | 1501 | 0.270 |
Why?
| | Proton Pump Inhibitors | 1 | 2008 | 100 | 0.270 |
Why?
| | Phosphorus | 1 | 2007 | 93 | 0.270 |
Why?
| | Delirium | 1 | 2008 | 78 | 0.270 |
Why?
| | Psoas Abscess | 1 | 2006 | 2 | 0.270 |
Why?
| | Methicillin Resistance | 1 | 2006 | 18 | 0.270 |
Why?
| | Infant | 10 | 2021 | 9025 | 0.270 |
Why?
| | Formates | 1 | 2006 | 13 | 0.270 |
Why?
| | Linear Models | 3 | 2015 | 819 | 0.270 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1220 | 0.260 |
Why?
| | Hypothermia | 2 | 2024 | 34 | 0.260 |
Why?
| | Explosions | 2 | 2021 | 9 | 0.260 |
Why?
| | Cohort Studies | 6 | 2023 | 5420 | 0.260 |
Why?
| | Blindness | 1 | 2006 | 38 | 0.260 |
Why?
| | Poisons | 2 | 2019 | 20 | 0.260 |
Why?
| | Models, Animal | 3 | 2024 | 376 | 0.260 |
Why?
| | Kaplan-Meier Estimate | 2 | 2018 | 857 | 0.260 |
Why?
| | Toxicity Tests, Acute | 2 | 2018 | 9 | 0.260 |
Why?
| | Child, Preschool | 10 | 2021 | 10518 | 0.250 |
Why?
| | Fentanyl | 2 | 2017 | 79 | 0.250 |
Why?
| | Zebrafish | 2 | 2022 | 458 | 0.250 |
Why?
| | Rabbits | 5 | 2021 | 778 | 0.250 |
Why?
| | Tertiary Care Centers | 2 | 2017 | 151 | 0.250 |
Why?
| | Intention | 1 | 2007 | 162 | 0.250 |
Why?
| | Hospitals | 2 | 2022 | 637 | 0.240 |
Why?
| | Biomarkers | 4 | 2024 | 3973 | 0.240 |
Why?
| | Psychotropic Drugs | 1 | 2005 | 69 | 0.240 |
Why?
| | Travel | 2 | 2016 | 122 | 0.240 |
Why?
| | Cocaine | 1 | 2007 | 149 | 0.240 |
Why?
| | Crotalid Venoms | 2 | 2011 | 31 | 0.240 |
Why?
| | Fat Emulsions, Intravenous | 2 | 2015 | 28 | 0.240 |
Why?
| | Double-Blind Method | 2 | 2015 | 1876 | 0.230 |
Why?
| | Diagnosis, Differential | 4 | 2015 | 1434 | 0.230 |
Why?
| | Cannabis | 1 | 2012 | 465 | 0.230 |
Why?
| | Suicide, Attempted | 4 | 2015 | 349 | 0.230 |
Why?
| | Hydrocarbons | 1 | 2004 | 27 | 0.230 |
Why?
| | Echocardiography | 2 | 2018 | 629 | 0.230 |
Why?
| | Terpenes | 1 | 2004 | 24 | 0.230 |
Why?
| | Risk | 2 | 2018 | 854 | 0.230 |
Why?
| | Research Design | 3 | 2015 | 1043 | 0.230 |
Why?
| | Child | 15 | 2021 | 20882 | 0.220 |
Why?
| | Equipment Reuse | 1 | 2024 | 14 | 0.220 |
Why?
| | Surveys and Questionnaires | 8 | 2017 | 5401 | 0.220 |
Why?
| | Limit of Detection | 3 | 2012 | 82 | 0.220 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5066 | 0.220 |
Why?
| | Pilot Projects | 4 | 2023 | 1587 | 0.220 |
Why?
| | Crotalus | 1 | 2004 | 26 | 0.220 |
Why?
| | Animal Experimentation | 1 | 2003 | 6 | 0.210 |
Why?
| | Neck Injuries | 1 | 2023 | 21 | 0.210 |
Why?
| | Noninvasive Ventilation | 1 | 2024 | 50 | 0.210 |
Why?
| | Glasgow Coma Scale | 1 | 2004 | 167 | 0.210 |
Why?
| | Shock, Traumatic | 1 | 2023 | 14 | 0.210 |
Why?
| | Mycophenolic Acid | 1 | 2004 | 110 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2535 | 0.210 |
Why?
| | Ventilators, Mechanical | 1 | 2023 | 56 | 0.200 |
Why?
| | Staphylococcus aureus | 1 | 2006 | 438 | 0.200 |
Why?
| | Fibrinolysis | 1 | 2023 | 137 | 0.200 |
Why?
| | Plant Extracts | 1 | 2004 | 199 | 0.200 |
Why?
| | Seasons | 1 | 2024 | 502 | 0.190 |
Why?
| | Follow-Up Studies | 5 | 2017 | 4896 | 0.190 |
Why?
| | Staphylococcal Infections | 1 | 2006 | 393 | 0.190 |
Why?
| | Toxicokinetics | 2 | 2018 | 9 | 0.180 |
Why?
| | Feasibility Studies | 2 | 2023 | 867 | 0.180 |
Why?
| | Emergency Responders | 1 | 2021 | 35 | 0.180 |
Why?
| | Memory | 1 | 2023 | 255 | 0.180 |
Why?
| | Soil Pollutants | 1 | 2020 | 17 | 0.180 |
Why?
| | Lactates | 2 | 2012 | 85 | 0.180 |
Why?
| | Heart Rate | 3 | 2015 | 801 | 0.180 |
Why?
| | Personal Protective Equipment | 1 | 2021 | 49 | 0.180 |
Why?
| | Consensus | 3 | 2021 | 615 | 0.180 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 185 | 0.170 |
Why?
| | Guidelines as Topic | 3 | 2017 | 264 | 0.170 |
Why?
| | Disulfides | 1 | 2020 | 97 | 0.170 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2020 | 14 | 0.170 |
Why?
| | Inhalation Exposure | 1 | 2020 | 91 | 0.170 |
Why?
| | Patient Outcome Assessment | 2 | 2021 | 125 | 0.170 |
Why?
| | Endovascular Procedures | 1 | 2024 | 301 | 0.160 |
Why?
| | Wounds, Nonpenetrating | 2 | 2021 | 273 | 0.160 |
Why?
| | Hypoxia | 2 | 2024 | 1084 | 0.160 |
Why?
| | Brain Concussion | 2 | 2023 | 548 | 0.160 |
Why?
| | Thiazoles | 2 | 2024 | 117 | 0.160 |
Why?
| | Agkistrodon | 1 | 2019 | 5 | 0.160 |
Why?
| | Brain Injuries | 2 | 2023 | 468 | 0.160 |
Why?
| | Aged | 8 | 2024 | 22099 | 0.160 |
Why?
| | Calcium | 2 | 2023 | 1213 | 0.160 |
Why?
| | Haloperidol | 1 | 2019 | 32 | 0.160 |
Why?
| | Ketorolac | 1 | 2019 | 21 | 0.160 |
Why?
| | Gases | 1 | 2019 | 44 | 0.160 |
Why?
| | Adrenergic Agonists | 1 | 2018 | 5 | 0.150 |
Why?
| | Terrorism | 1 | 2018 | 24 | 0.150 |
Why?
| | Harm Reduction | 1 | 2019 | 32 | 0.150 |
Why?
| | Sodium Cyanide | 1 | 2018 | 1 | 0.150 |
Why?
| | Immunosuppressive Agents | 1 | 2004 | 853 | 0.150 |
Why?
| | Blood Circulation | 1 | 2018 | 41 | 0.150 |
Why?
| | Documentation | 1 | 2020 | 184 | 0.150 |
Why?
| | Logistic Models | 3 | 2024 | 1988 | 0.150 |
Why?
| | Tympanic Membrane Perforation | 2 | 2009 | 15 | 0.150 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2018 | 8 | 0.150 |
Why?
| | Reproducibility of Results | 3 | 2013 | 3083 | 0.150 |
Why?
| | Torso | 1 | 2018 | 31 | 0.150 |
Why?
| | War Exposure | 1 | 2018 | 10 | 0.150 |
Why?
| | Cholinesterase Inhibitors | 1 | 2018 | 29 | 0.150 |
Why?
| | Saliva | 1 | 2019 | 209 | 0.150 |
Why?
| | Dextropropoxyphene | 1 | 2017 | 3 | 0.150 |
Why?
| | Tramadol | 1 | 2017 | 10 | 0.140 |
Why?
| | Vascular Access Devices | 1 | 2018 | 26 | 0.140 |
Why?
| | Methemoglobinemia | 1 | 2017 | 13 | 0.140 |
Why?
| | Burns, Inhalation | 1 | 2017 | 9 | 0.140 |
Why?
| | Blood Proteins | 1 | 2019 | 242 | 0.140 |
Why?
| | Analysis of Variance | 2 | 2017 | 1288 | 0.140 |
Why?
| | Drug Prescriptions | 2 | 2020 | 248 | 0.140 |
Why?
| | Tidal Volume | 1 | 2018 | 84 | 0.140 |
Why?
| | Solid Phase Extraction | 2 | 2019 | 23 | 0.140 |
Why?
| | Acidosis | 2 | 2009 | 89 | 0.140 |
Why?
| | Rescue Work | 1 | 2017 | 8 | 0.140 |
Why?
| | Disease Management | 3 | 2017 | 589 | 0.140 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 422 | 0.140 |
Why?
| | Hemoglobins | 2 | 2018 | 339 | 0.140 |
Why?
| | Blood Coagulation | 1 | 2018 | 238 | 0.130 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2015 | 398 | 0.130 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 69 | 0.130 |
Why?
| | Dextromethorphan | 1 | 2016 | 18 | 0.130 |
Why?
| | Epidemics | 1 | 2018 | 82 | 0.130 |
Why?
| | Sodium Chloride | 1 | 2017 | 138 | 0.130 |
Why?
| | Antacids | 1 | 2016 | 16 | 0.130 |
Why?
| | Telephone | 1 | 2017 | 167 | 0.130 |
Why?
| | Shock, Septic | 1 | 2019 | 209 | 0.130 |
Why?
| | Headache | 1 | 2017 | 151 | 0.130 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1206 | 0.130 |
Why?
| | Educational Status | 2 | 2016 | 470 | 0.130 |
Why?
| | Medical Errors | 1 | 2017 | 104 | 0.130 |
Why?
| | Clinical Protocols | 1 | 2018 | 255 | 0.130 |
Why?
| | Inpatients | 1 | 2020 | 467 | 0.130 |
Why?
| | Pharmacy Service, Hospital | 1 | 2017 | 90 | 0.130 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2016 | 91 | 0.130 |
Why?
| | Algorithms | 2 | 2016 | 1622 | 0.130 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 339 | 0.130 |
Why?
| | Decision Trees | 1 | 2016 | 90 | 0.130 |
Why?
| | Point-of-Care Testing | 1 | 2016 | 32 | 0.130 |
Why?
| | Prognosis | 2 | 2019 | 3794 | 0.120 |
Why?
| | Prescription Drug Diversion | 1 | 2015 | 12 | 0.120 |
Why?
| | Massachusetts | 1 | 2016 | 159 | 0.120 |
Why?
| | Heart Diseases | 1 | 2019 | 350 | 0.120 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 198 | 0.120 |
Why?
| | Radiation Injuries | 1 | 2017 | 135 | 0.120 |
Why?
| | Benzodiazepines | 1 | 2016 | 136 | 0.120 |
Why?
| | Sepsis | 1 | 2021 | 574 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2023 | 1367 | 0.120 |
Why?
| | Drug Costs | 1 | 2016 | 100 | 0.120 |
Why?
| | Disaster Planning | 1 | 2016 | 82 | 0.120 |
Why?
| | Zebrafish Proteins | 1 | 2018 | 265 | 0.120 |
Why?
| | Drug Utilization Review | 1 | 2015 | 57 | 0.120 |
Why?
| | Breast Neoplasms | 1 | 2007 | 2142 | 0.120 |
Why?
| | Methotrexate | 1 | 2016 | 249 | 0.120 |
Why?
| | Angiography | 2 | 2013 | 195 | 0.120 |
Why?
| | Proteome | 1 | 2019 | 443 | 0.120 |
Why?
| | Equipment Design | 2 | 2024 | 513 | 0.120 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1201 | 0.120 |
Why?
| | Phenols | 1 | 2015 | 97 | 0.120 |
Why?
| | Metabolome | 1 | 2018 | 338 | 0.120 |
Why?
| | Clinical Competence | 2 | 2014 | 1016 | 0.120 |
Why?
| | Practice Patterns, Nurses' | 1 | 2014 | 19 | 0.110 |
Why?
| | Vitamin B Complex | 1 | 2014 | 41 | 0.110 |
Why?
| | Shock | 2 | 2012 | 92 | 0.110 |
Why?
| | Thyroid Cartilage | 1 | 2014 | 4 | 0.110 |
Why?
| | Nurses | 1 | 2016 | 164 | 0.110 |
Why?
| | Anesthesia, General | 1 | 2014 | 54 | 0.110 |
Why?
| | Societies, Medical | 1 | 2018 | 751 | 0.110 |
Why?
| | Aspartate Aminotransferases | 1 | 2014 | 88 | 0.110 |
Why?
| | Mortality | 1 | 2016 | 307 | 0.110 |
Why?
| | Teaching Rounds | 1 | 2015 | 68 | 0.110 |
Why?
| | Liver Function Tests | 1 | 2014 | 112 | 0.110 |
Why?
| | Health Services Research | 1 | 2016 | 391 | 0.110 |
Why?
| | Anesthetics | 1 | 2014 | 66 | 0.110 |
Why?
| | Aged, 80 and over | 3 | 2016 | 7084 | 0.110 |
Why?
| | Length of Stay | 2 | 2016 | 1127 | 0.110 |
Why?
| | Ketoglutaric Acids | 1 | 2013 | 15 | 0.110 |
Why?
| | Mentors | 1 | 2015 | 178 | 0.110 |
Why?
| | Alanine Transaminase | 1 | 2014 | 153 | 0.110 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 253 | 0.110 |
Why?
| | Ischemia | 2 | 2014 | 406 | 0.110 |
Why?
| | Central Nervous System Stimulants | 1 | 2015 | 154 | 0.110 |
Why?
| | Necrosis | 1 | 2014 | 232 | 0.100 |
Why?
| | Academic Medical Centers | 1 | 2016 | 481 | 0.100 |
Why?
| | Drug Combinations | 1 | 2014 | 330 | 0.100 |
Why?
| | Proteomics | 1 | 2019 | 1062 | 0.100 |
Why?
| | Health Surveys | 1 | 2015 | 494 | 0.100 |
Why?
| | Metabolomics | 1 | 2018 | 652 | 0.100 |
Why?
| | Tertiary Healthcare | 1 | 2012 | 29 | 0.100 |
Why?
| | Common Cold | 1 | 2012 | 13 | 0.100 |
Why?
| | Drug Stability | 1 | 2013 | 159 | 0.100 |
Why?
| | Data Collection | 1 | 2015 | 650 | 0.100 |
Why?
| | Nitriles | 1 | 2013 | 172 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 2012 | 0.100 |
Why?
| | Respiratory System Agents | 1 | 2012 | 22 | 0.100 |
Why?
| | Chromatography, Thin Layer | 1 | 2012 | 23 | 0.100 |
Why?
| | Basilar Artery | 1 | 2012 | 6 | 0.100 |
Why?
| | Blood Chemical Analysis | 1 | 2012 | 96 | 0.100 |
Why?
| | Cadaver | 2 | 2024 | 306 | 0.100 |
Why?
| | Safety | 2 | 2013 | 331 | 0.100 |
Why?
| | Cues | 1 | 2014 | 326 | 0.100 |
Why?
| | Nonprescription Drugs | 1 | 2012 | 66 | 0.090 |
Why?
| | Triage | 2 | 2017 | 206 | 0.090 |
Why?
| | Fever | 1 | 2013 | 298 | 0.090 |
Why?
| | Risk Assessment | 2 | 2018 | 3240 | 0.090 |
Why?
| | Cough | 1 | 2012 | 115 | 0.090 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 80 | 0.090 |
Why?
| | Abbreviated Injury Scale | 2 | 2021 | 22 | 0.090 |
Why?
| | Femur | 1 | 2013 | 244 | 0.090 |
Why?
| | Patient Satisfaction | 1 | 2015 | 633 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 544 | 0.090 |
Why?
| | Health Care Surveys | 1 | 2012 | 559 | 0.090 |
Why?
| | Drug Administration Routes | 1 | 2010 | 39 | 0.090 |
Why?
| | Needlestick Injuries | 1 | 2010 | 4 | 0.090 |
Why?
| | Pain, Postoperative | 1 | 2012 | 233 | 0.090 |
Why?
| | Sleep Stages | 1 | 2010 | 45 | 0.080 |
Why?
| | Mice | 4 | 2023 | 16937 | 0.080 |
Why?
| | Tissue Plasminogen Activator | 1 | 2012 | 222 | 0.080 |
Why?
| | Nausea | 1 | 2010 | 110 | 0.080 |
Why?
| | Vomiting | 1 | 2010 | 128 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 263 | 0.080 |
Why?
| | Manikins | 1 | 2009 | 24 | 0.080 |
Why?
| | Curriculum | 1 | 2015 | 916 | 0.080 |
Why?
| | Allied Health Personnel | 1 | 2009 | 41 | 0.080 |
Why?
| | Anaphylaxis | 1 | 2010 | 98 | 0.080 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2017 | 825 | 0.080 |
Why?
| | Mental Health | 1 | 2015 | 686 | 0.080 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1838 | 0.070 |
Why?
| | Inservice Training | 1 | 2009 | 114 | 0.070 |
Why?
| | Patient Care Team | 1 | 2013 | 605 | 0.070 |
Why?
| | Electronic Health Records | 1 | 2015 | 975 | 0.070 |
Why?
| | Thoracostomy | 1 | 2007 | 17 | 0.070 |
Why?
| | Decision Support Systems, Clinical | 2 | 2021 | 205 | 0.070 |
Why?
| | Dermis | 1 | 2007 | 31 | 0.070 |
Why?
| | Unconsciousness | 1 | 2007 | 19 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 1 | 2010 | 317 | 0.070 |
Why?
| | Risk Factors | 5 | 2017 | 9763 | 0.070 |
Why?
| | Spectrum Analysis | 2 | 2018 | 89 | 0.070 |
Why?
| | Primary Health Care | 2 | 2020 | 1679 | 0.070 |
Why?
| | Decision Support Techniques | 1 | 2011 | 396 | 0.070 |
Why?
| | Fatal Outcome | 1 | 2007 | 300 | 0.070 |
Why?
| | Sodium Channels | 1 | 2007 | 63 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2742 | 0.070 |
Why?
| | Vasopressins | 1 | 2006 | 64 | 0.060 |
Why?
| | Atomoxetine Hydrochloride | 1 | 2005 | 4 | 0.060 |
Why?
| | Propylamines | 1 | 2005 | 11 | 0.060 |
Why?
| | Vasoconstrictor Agents | 1 | 2006 | 127 | 0.060 |
Why?
| | Oxygen Consumption | 2 | 2019 | 672 | 0.060 |
Why?
| | Death, Sudden | 1 | 2005 | 24 | 0.060 |
Why?
| | Treatment Failure | 1 | 2007 | 340 | 0.060 |
Why?
| | Valproic Acid | 1 | 2005 | 47 | 0.060 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2007 | 119 | 0.060 |
Why?
| | Vasospasm, Intracranial | 1 | 2005 | 17 | 0.060 |
Why?
| | Health Services Accessibility | 1 | 2012 | 902 | 0.060 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2005 | 64 | 0.060 |
Why?
| | Dimethylformamide | 1 | 2004 | 1 | 0.060 |
Why?
| | Kerosene | 1 | 2004 | 1 | 0.060 |
Why?
| | Hexanones | 1 | 2004 | 2 | 0.060 |
Why?
| | Administration, Inhalation | 1 | 2006 | 666 | 0.060 |
Why?
| | Hexanes | 1 | 2004 | 4 | 0.060 |
Why?
| | Cyclohexenes | 1 | 2004 | 7 | 0.060 |
Why?
| | Community-Acquired Infections | 1 | 2006 | 161 | 0.060 |
Why?
| | Alkanes | 1 | 2004 | 14 | 0.060 |
Why?
| | Forensic Toxicology | 1 | 2024 | 2 | 0.060 |
Why?
| | Dimethyl Sulfoxide | 1 | 2004 | 41 | 0.060 |
Why?
| | Linoleic Acid | 1 | 2004 | 41 | 0.060 |
Why?
| | Oleic Acid | 1 | 2004 | 39 | 0.060 |
Why?
| | Electric Power Supplies | 1 | 2024 | 49 | 0.060 |
Why?
| | Catheters | 1 | 2024 | 68 | 0.060 |
Why?
| | Charcoal | 1 | 2004 | 24 | 0.060 |
Why?
| | Sorbitol | 1 | 2023 | 14 | 0.050 |
Why?
| | Blood Cell Count | 1 | 2004 | 52 | 0.050 |
Why?
| | Parents | 1 | 2012 | 1309 | 0.050 |
Why?
| | Lupus Nephritis | 1 | 2004 | 49 | 0.050 |
Why?
| | Masks | 1 | 2024 | 59 | 0.050 |
Why?
| | Half-Life | 2 | 2014 | 162 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2005 | 209 | 0.050 |
Why?
| | Fibrin | 1 | 2004 | 70 | 0.050 |
Why?
| | Rats | 2 | 2022 | 5499 | 0.050 |
Why?
| | Observer Variation | 1 | 2004 | 315 | 0.050 |
Why?
| | Specimen Handling | 1 | 2024 | 164 | 0.050 |
Why?
| | Fibrinogen | 1 | 2004 | 164 | 0.050 |
Why?
| | Ambulances | 1 | 2023 | 51 | 0.050 |
Why?
| | Video Recording | 1 | 2023 | 164 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2023 | 56 | 0.050 |
Why?
| | Hemostasis | 1 | 2023 | 79 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2005 | 366 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2019 | 582 | 0.050 |
Why?
| | Intracranial Hemorrhages | 1 | 2023 | 80 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2023 | 170 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2022 | 52 | 0.050 |
Why?
| | Armed Conflicts | 1 | 2021 | 10 | 0.050 |
Why?
| | Blood Coagulation Disorders | 1 | 2023 | 167 | 0.050 |
Why?
| | Bandages | 1 | 2021 | 32 | 0.050 |
Why?
| | Cricetulus | 1 | 2021 | 107 | 0.050 |
Why?
| | CHO Cells | 1 | 2021 | 153 | 0.050 |
Why?
| | Aviation | 1 | 2021 | 7 | 0.050 |
Why?
| | Fumigation | 1 | 2020 | 3 | 0.050 |
Why?
| | Cricetinae | 1 | 2021 | 277 | 0.040 |
Why?
| | Temperature | 1 | 2024 | 636 | 0.040 |
Why?
| | Sheep | 1 | 2004 | 837 | 0.040 |
Why?
| | Hypertension | 1 | 2010 | 1242 | 0.040 |
Why?
| | Hydrazines | 1 | 2021 | 34 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2406 | 0.040 |
Why?
| | Oximetry | 1 | 2021 | 87 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3144 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 286 | 0.040 |
Why?
| | Pesticides | 1 | 2020 | 58 | 0.040 |
Why?
| | Hemolysis | 1 | 2022 | 199 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 271 | 0.040 |
Why?
| | Intersectoral Collaboration | 1 | 2020 | 60 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2025 | 738 | 0.040 |
Why?
| | Myocardial Infarction | 1 | 2007 | 1022 | 0.040 |
Why?
| | Quality Improvement | 2 | 2021 | 1101 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 179 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 993 | 0.040 |
Why?
| | Directive Counseling | 1 | 2019 | 46 | 0.040 |
Why?
| | Phosphorylation | 1 | 2023 | 1713 | 0.040 |
Why?
| | Cholinesterase Reactivators | 1 | 2018 | 1 | 0.040 |
Why?
| | Organophosphate Poisoning | 1 | 2018 | 1 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2018 | 57 | 0.040 |
Why?
| | North America | 1 | 2019 | 291 | 0.040 |
Why?
| | Drug Storage | 1 | 2018 | 57 | 0.040 |
Why?
| | Hospitalization | 2 | 2019 | 2070 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2021 | 5762 | 0.040 |
Why?
| | Resource Allocation | 1 | 2018 | 39 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1502 | 0.040 |
Why?
| | Catheterization, Peripheral | 1 | 2019 | 104 | 0.040 |
Why?
| | Hippocampus | 1 | 2023 | 874 | 0.040 |
Why?
| | Peptides | 1 | 2023 | 925 | 0.040 |
Why?
| | Multiple Trauma | 1 | 2018 | 101 | 0.030 |
Why?
| | Antipsychotic Agents | 1 | 2019 | 195 | 0.030 |
Why?
| | Burn Units | 1 | 2016 | 42 | 0.030 |
Why?
| | Chemical Warfare Agents | 1 | 2018 | 121 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2018 | 260 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2020 | 635 | 0.030 |
Why?
| | Disasters | 1 | 2016 | 91 | 0.030 |
Why?
| | Advisory Committees | 1 | 2016 | 216 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2020 | 741 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 173 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 1033 | 0.030 |
Why?
| | Inactivation, Metabolic | 1 | 2014 | 11 | 0.030 |
Why?
| | Recovery of Function | 1 | 2018 | 642 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1952 | 0.030 |
Why?
| | Neurons | 1 | 2023 | 1511 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2014 | 147 | 0.030 |
Why?
| | Drug Approval | 1 | 2014 | 88 | 0.030 |
Why?
| | Eating | 1 | 2016 | 369 | 0.030 |
Why?
| | Thiazolidines | 1 | 2013 | 9 | 0.030 |
Why?
| | Pharmacokinetics | 1 | 2013 | 29 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 2013 | 109 | 0.030 |
Why?
| | Qualitative Research | 1 | 2020 | 1234 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2013 | 37 | 0.030 |
Why?
| | Species Specificity | 1 | 2014 | 575 | 0.030 |
Why?
| | Teaching | 1 | 2015 | 214 | 0.030 |
Why?
| | Traumatology | 1 | 2012 | 25 | 0.030 |
Why?
| | Educational Measurement | 1 | 2015 | 262 | 0.030 |
Why?
| | Critical Care Nursing | 1 | 2013 | 36 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2014 | 216 | 0.020 |
Why?
| | Quality Control | 1 | 2012 | 163 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1214 | 0.020 |
Why?
| | Infusions, Intra-Arterial | 1 | 2012 | 53 | 0.020 |
Why?
| | Organizational Innovation | 1 | 2012 | 138 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 117 | 0.020 |
Why?
| | Arginine | 1 | 2013 | 265 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3381 | 0.020 |
Why?
| | United States Food and Drug Administration | 1 | 2012 | 204 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 672 | 0.020 |
Why?
| | Acute Coronary Syndrome | 1 | 2014 | 267 | 0.020 |
Why?
| | Fingers | 1 | 2010 | 86 | 0.020 |
Why?
| | Explosive Agents | 1 | 2009 | 6 | 0.020 |
Why?
| | Delphi Technique | 1 | 2011 | 224 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2736 | 0.020 |
Why?
| | Injections | 1 | 2010 | 174 | 0.020 |
Why?
| | Thrombosis | 1 | 2013 | 343 | 0.020 |
Why?
| | Comorbidity | 1 | 2013 | 1547 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2010 | 326 | 0.020 |
Why?
| | Pulse | 1 | 2006 | 23 | 0.020 |
Why?
| | Immunoassay | 1 | 2007 | 107 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2006 | 138 | 0.020 |
Why?
| | Electric Countershock | 1 | 2006 | 105 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2007 | 234 | 0.020 |
Why?
| | Delivery of Health Care | 1 | 2012 | 893 | 0.020 |
Why?
| | Haplorhini | 1 | 2005 | 50 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2013 | 2483 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3408 | 0.010 |
Why?
|
|
Bebarta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|